Robert C Castellino
Emory & Henry College
H-index: 24
North America-United States
Top articles of Robert C Castellino
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial
Neuro-oncology
2024/2/1
Robert C Castellino
H-Index: 15
William Martin
H-Index: 5
Vijay Ramaswamy
H-Index: 52
Amy Smith
H-Index: 2
Christopher Smith
H-Index: 0
A pilot study omitting radiation in the treatment of children with newly diagnosed Wnt-activated medulloblastoma
Clinical Cancer Research
2023/12/15
HGG-28. INTERIM ANALYSIS OF THE GCC1949 PHASE 2 TRIAL USING INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS
Neuro-Oncology
2023/6/1
Robert C Castellino
H-Index: 15
LGG-23. OUTCOMES UTILIZING BRAF INHIBITION MONOTHERAPY IN BRAFV600E MUTATED PEDIATRIC LOW GRADE GLIOMAS
Neuro-Oncology
2023/6/1
A phase 2 study of sirolimus in combination with metronomic chemotherapy (CHOAnome) in children with recurrent and/or refractory solid and CNS tumors.
2023/6/1
CTIM-32. FIRST-IN-CHILDREN PHASE 1 TRIAL OF INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS: ANALYSIS OF SAFETY, TOLERABILITY, AND 5-YEAR OUTCOME
2022/11/1
RARE-28. The use of subcutaneous interferon in patients with craniopharyngioma: an institutional retrospective review
Neuro-Oncology
2022/6
LGG-64. A phase II study of pegylated interferon in children with recurrent or refractory and radiographically or clinically progressive juvenile pilocytic astrocytomas and …
Neuro-Oncology
2022/6
OTHR-08. Pediatric Neurologic Assessment in Neuro-oncology (pNANO) Scale: A tool to assess neurologic function for Response Assessment in Neuro-oncology (RAPNO)
Neuro-Oncology
2022/6
Comprehensive genomic profiling of high-risk pediatric cancer patients has a measurable impact on clinical care
JCO Precision Oncology
2022/5
Synthetic extracellular matrices and astrocytes provide a supportive microenvironment for the cultivation and investigation of primary pediatric gliomas
Neuro-Oncology Advances
2022/1/1
Immu-04. First-in-children phase 1b study using the ido pathway inhibitor indoximod in combination with radiation and chemotherapy for children with newly diagnosed DIPG …
Neuro-Oncology
2021/6/1
Ten-eleven translocation protein 1 modulates medulloblastoma progression
Genome Biology
2021/4/29
Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer
2021/2/1
MBCL-25. pilot study of a surgery and chemotherapy-only approach in the upfront therapy of children with wnt-positive standard risk medulloblastoma: updated outcomes
Neuro-Oncology
2020/12
Correction: Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling
Oncotarget
2020/11/11
Lily Yang
H-Index: 37
Robert C Castellino
H-Index: 15
Insulin-Like Growth Factor-1 Receptor Signaling Increases the Invasive Potential of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Cells via Src-Focal …
Cell Death & Differentiation
2004/7
